Physician
New York Primary Care Medicine PC
New York Primary Care Medicine PC was paid $179K by Medicaid between Jan 2018 and May 2024, across 127 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoNEW YORK PRIMARY CARE MEDICINE PC
NEW YORK, NY 10033
NEW YORK, NY 10033
33aNPI1093815771assigned 09/23/2006
33bProvider typeFamily Medicine Physician
28Total paid$179K
24GClaims109,727
24DCodes billed127
24AFirst – last monthJan 2018 – May 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#432 of 2,605
Median peer was paid$10K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,281 | $64K | |
| 2019 | 18,564 | $51K | |
| 2020 | 14,027 | $21K | |
| 2021 | 13,077 | $13K | |
| 2022 | 17,012 | $11K | |
| 2023 | 24,050 | $18K | |
| 2024incomplete | 7,716 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 5,045 | 4,409 | $49K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 1,359 | 1,297 | $26K |
| 93000 | 8.6% | 1,107 | 1,098 | $15K | |
| G0444 | Annual depression screening, 5 to 15 minutes | 6.6% | 936 | 930 | $12K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 6.3% | 649 | 647 | $11K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 6.2% | 926 | 908 | $11K |
| 99497 | 3.7% | 384 | 381 | $7K | |
| 3074F | 2.8% | 3,210 | 2,707 | $5K | |
| 3078F | 2.4% | 2,850 | 2,437 | $4K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 2.4% | 365 | 325 | $4K |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 2.0% | 408 | 389 | $4K |
| 99442 | 1.3% | 183 | 176 | $2K |
115 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 87 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 1,189 | $2K |
| 3077F | 1.1% | 818 | $2K | |
| 3079F | 1.0% | 1,245 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 398 | $2K |
| 3080F | <1% | 700 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,175 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 132 | $2K |
| 1170F | <1% | 1,923 | $2K | |
| 1126F | <1% | 3,777 | $2K | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 6,517 | $1K |
| 82948 | <1% | 2,747 | $1K | |
| 3075F | <1% | 657 | $945.05 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 189 | $908.82 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,324 | $770.11 |
| 1159F | <1% | 4,704 | $764.00 | |
| 1160F | <1% | 4,731 | $556.50 | |
| 3061F | <1% | 1,979 | $480.00 | |
| G0443 | Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes | <1% | 107 | $441.46 |
| 3044F | <1% | 1,293 | $438.01 | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 15 | $361.44 |
| 99401 | <1% | 404 | $356.49 | |
| 0521F | <1% | 646 | $328.00 | |
| 1125F | <1% | 777 | $249.00 | |
| 90674 | <1% | 97 | $178.45 | |
| 3049F | <1% | 633 | $160.00 | |
| 3050F | <1% | 420 | $104.00 | |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | <1% | 451 | $90.00 |
| 97803 | <1% | 90 | $63.42 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 199 | $42.53 |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 47 | $17.78 |
| 81000 | <1% | 772 | $15.28 | |
| H0001 | Alcohol and/or drug assessment | <1% | 944 | $10.37 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 1,642 | $9.00 |
| 94760 | <1% | 2,544 | $2.88 | |
| 81002 | <1% | 58 | $2.02 | |
| 3048F | <1% | 1,155 | $0.44 | |
| 3511F | <1% | 381 | $0.28 | |
| 3008F | <1% | 4,513 | $0.25 | |
| M1189 | Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed | <1% | 253 | $0.20 |
| 90732 | <1% | 12 | $0.04 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | <1% | 1,410 | $0.01 |
| G9507 | Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) | <1% | 900 | $0.01 |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | <1% | 539 | $0.01 |
| G9228 | Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings) | 0% | 61 | $0.00 |
| 1000F | 0% | 295 | $0.00 | |
| 3351F | 0% | 64 | $0.00 | |
| 4086F | 0% | 299 | $0.00 | |
| 99429 | 0% | 318 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 2,533 | $0.00 |
| 97802 | 0% | 150 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 134 | $0.00 |
| 2001F | 0% | 4,445 | $0.00 | |
| 1036F | 0% | 1,618 | $0.00 | |
| 2000F | 0% | 4,747 | $0.00 | |
| G8473 | Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed | 0% | 538 | $0.00 |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 622 | $0.00 |
| 3011F | 0% | 1,386 | $0.00 | |
| 99000 | 0% | 1,014 | $0.00 | |
| 4010F | 0% | 505 | $0.00 | |
| G9278 | Documentation that the patient is not on daily aspirin or anti-platelet regimen | 0% | 270 | $0.00 |
| G2197 | Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user | 0% | 135 | $0.00 |
| G0475 | Hiv antigen/antibody, combination assay, screening | 0% | 207 | $0.00 |
| 1157F | 0% | 109 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 131 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 1,208 | $0.00 |
| M1200 | Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period | 0% | 268 | $0.00 |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | 0% | 529 | $0.00 |
| 3014F | 0% | 12 | $0.00 | |
| 4000F | 0% | 19 | $0.00 | |
| 81001 | 0% | 27 | $0.00 | |
| 4450F | 0% | 85 | $0.00 | |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 13 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 262 | $0.00 |
| G8475 | Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given | 0% | 214 | $0.00 |
| G8599 | Aspirin or another antiplatelet therapy not used, reason not given | 0% | 304 | $0.00 |
| G9793 | Patient is currently on a daily aspirin or other antiplatelet | 0% | 120 | $0.00 |
| 3017F | 0% | 105 | $0.00 | |
| S0257 | Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service) | 0% | 66 | $0.00 |
| 3512F | 0% | 67 | $0.00 | |
| G9508 | Documentation that the patient is not on a statin medication | 0% | 148 | $0.00 |
| 99406 | 0% | 13 | $0.00 | |
| 0513F | 0% | 23 | $0.00 | |
| M1207 | Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety | 0% | 46 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 56 | $0.00 |
| 1031F | 0% | 16 | $0.00 | |
| 1123F | 0% | 14 | $0.00 | |
| 1158F | 0% | 251 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 516 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 1,118 | $0.00 |
| 99072 | 0% | 1,283 | $0.00 | |
| G9820 | Documentation of a chlamydia screening test with proper follow-up | 0% | 240 | $0.00 |
| 3016F | 0% | 1,116 | $0.00 | |
| 4013F | 0% | 1,430 | $0.00 | |
| G8935 | Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 609 | $0.00 |
| G9796 | Patient is currently on a high intensity statin therapy | 0% | 574 | $0.00 |
| 3725F | 0% | 1,122 | $0.00 | |
| G9665 | Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy | 0% | 182 | $0.00 |
| G8506 | Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 388 | $0.00 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 191 | $0.00 |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 292 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 814 | $0.00 |
| 3288F | 0% | 236 | $0.00 | |
| G9797 | Patient is not on a high intensity statin therapy | 0% | 222 | $0.00 |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | 0% | 80 | $0.00 |
| M1055 | Aspirin or another antiplatelet therapy used | 0% | 51 | $0.00 |
| G8937 | Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given | 0% | 159 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 70 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 188 | $0.00 |
| G2010 | Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment | 0% | 164 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 35 | $0.00 |
| 80061 | Lipid panel | 0% | 26 | $0.00 |
| G0468 | Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv | 0% | 35 | $0.00 |
| G0445 | High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes | 0% | 110 | $0.00 |
| A4206 | Syringe with needle, sterile, 1 cc or less, each | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHABLA, JUAN (PRESIDENT)